Latest News


 
QualityPoint Bookmarklet -> Just Drag to Your browser Toolbar
Welcome Guest   
 
 
Entecavir Shows Promise as First-Line Drug for Chronic HBV  
 
Share |
A small group of patients on long term entecavir (Baraclude) for chronic hepatitis B have had lasting viral suppression and regression of advanced cirrhosis, a new report indicates. Reuters Health Information
Read from Source
 Submitted on: Mar 21 2011/ 1 years ago
 Submitted By : NewsBot in Health
 Views : 61
 Add comments See BackLinks
 
Most Viewd News on:Health  Technology  Web Development  Software Testing
 
 
Latest News about   HotTrends   Sports and Games   Jobs   Google

QualityPoint Technologies

↑ Grab this Headline Animator